Results 51 to 60 of about 3,112 (224)

Neural and metabolic dysregulation in PMM2-deficient human in vitro neural models

Cell Reports
Summary: Phosphomannomutase 2-congenital disorder of glycosylation (PMM2-CDG) is a rare inborn error of metabolism caused by deficiency of the PMM2 enzyme, which leads to impaired protein glycosylation.
Silvia Radenkovic, Rohit Budhraja, Teun Klein-Gunnewiek, Alexia Tyler King, Tarun N. Bhatia, Anna N. Ligezka, Karen Driesen, Rameen Shah, Bart Ghesquière, Akhilesh Pandey, Nael Nadif Kasri, Steven A. Sloan, Eva Morava, Tamas Kozicz   +13 more
doaj   +1 more source

Congenital muscular dystrophy: from muscle to brain. [PDF]

, 2016
Congenital muscular dystrophies (CMDs) are a wide group of muscular disorders that manifest with very early onset of muscular weakness, sometime associated to severe brain involvement.The histologic pattern of muscle anomalies is typical of dystrophic ...
Corsello G, Falsaperla R, Parano E, Pavone P, Praticò AD, Rizzo R, Ruggieri M, Vitaliti G   +7 more
core   +1 more source

Glycosphingolipids in congenital disorders of glycosylation (CDG)

Molecular Genetics and Metabolism
Congenital disorders of glycosylation (CDG) are a large family of rare disorders affecting the different glycosylation pathways. Defective glycosylation can affect any organ, with varying symptoms among the different CDG. Even between individuals with the same CDG there is quite variable severity.
Pedrayes, Andrea Janez, Rymen, Daisy, Ghesquiere, Bart, Witters, Peter   +3 more
openaire   +3 more sources

RFT1‐CDG: Deafness as a novel feature of congenital disorders of glycosylation [PDF]

Journal of Inherited Metabolic Disease, 2009
SummaryCongenital disorders of glycosylation (CDG) are genetic diseases due to defects in the synthesis of glycans and in the attachment of glycans to lipids and proteins. Actually, some 42 CDG are known including defects in protein N‐glycosylation, in protein O‐glycosylation, in lipid glycosylation, and in multiple and other glycosylation pathways ...
Jaeken, J, Vleugels, W, Régal, L, Corchia, C, Goemans, N, Haeuptle, M A, Foulquier, F, Hennet, T, Matthijs, G, Dionisi-Vici, C   +9 more
openaire   +2 more sources

Mannose phosphate isomerase-congenital disorder of glycosylation leads to asymptomatic hypoglycemia

Molecular Genetics and Metabolism Reports
Background: Mannose phosphate isomerase deficiency-congenital glycosylation disorders (MPI-CDG) is a rare autosomal recessive disorder caused by pathogenic variants in the MPI gene and characterized by digestive, hepatic, and endocrine-related symptoms ...
Cheng Luo, Danxia Peng, Yanyan Li, Shuping Liu, Qiong Wu, Xuan Xu, Jie Wen   +6 more
doaj   +1 more source

Antithrombin: Deficiency, Diversity, and the Future of Diagnostics

Mass Spectrometry Reviews, EarlyView.
ABSTRACT Our healthcare system provides reactive sick‐care, treating patients after symptoms have appeared by prescription of generic and often suboptimal therapy. This strategy brings along high costs and high pressure which is not sustainable.
Mirjam Kruijt, Christa M. Cobbaert, L. Renee Ruhaak   +2 more
wiley   +1 more source

MAN1B1 deficiency: an unexpected CDG-II. [PDF]

PLoS Genetics, 2013
Congenital disorders of glycosylation (CDG) are a group of rare metabolic diseases, due to impaired protein and lipid glycosylation. In the present study, exome sequencing was used to identify MAN1B1 as the culprit gene in an unsolved CDG-II patient ...
Daisy Rymen, Romain Peanne, María B Millón, Valérie Race, Luisa Sturiale, Domenico Garozzo, Philippa Mills, Peter Clayton, Carla G Asteggiano, Dulce Quelhas, Ali Cansu, Esmeralda Martins, Marie-Cécile Nassogne, Miguel Gonçalves-Rocha, Haluk Topaloglu, Jaak Jaeken, François Foulquier, Gert Matthijs   +17 more
doaj   +1 more source

What was that again, Congenital Disorder of Glycosylation? [PDF]

, 2012
New technology and research are continuously changing our understanding of the human body, and newly emerging diseases are continuously being discovered, such as Congenital Disorder of Glycosylation (CDG).
Roberts, Janelle
core   +2 more sources

Caenorhabditis elegans as an in vivo model system for human inherited primary arrhythmia syndromes

The Journal of Physiology, EarlyView.
Abstract figure legend Most genes involved in inherited primary arrhythmia syndromes (IPAS) are conserved in Caenorhabditis elegans, where genetic manipulation enables functional characterization of variants, identification of regulatory proteins, and in vivo drug testing.
Antoine Delinière, Thomas Boulin, Maëlle Jospin, Alexandre Janin, Gilles Millat, Philippe Chevalier, Olga Andrini   +6 more
wiley   +1 more source

Phosphomannomutase deficiency (PMM2-CDG): Ataxia and cerebellar assessment [PDF]

, 2015
Background: Phosphomannomutase deficiency (PMM2-CDG) is the most frequent congenital disorder of glycosylation. The cerebellum is nearly always affected in PMM2-CDG patients, a cerebellar atrophy progression is observed, and cerebellar dysfunction is ...
Artuch, R., Boix, Cristina, Briones, Paz, Carratalá, Francisco, Cuadras, Daniel, De Diego, Victor, Felipe-Rucián, Ana, Fons, Carmen, García-Cazorla, Angels, Girós, Marisa, Gort, Laura, Hospital Universitari Vall d'Hebron. Secció de Neurologia Pediàtrica, Jaeken, Jaak, Macaya Ruiz, Alfons, Muchart, Jordi, O'Callaghan, M. Mar, Poo, M. Pilar, Pérez, Belén, Pérez-Cerdá, Celia, Pérez-Dueñas, Belén, Robles, Bernabé, Serrano, Mercedes, Universitat Autònoma de Barcelona, Velázquez-Fragua, Ramón   +23 more
core   +3 more sources